New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
08:56 EDTPIPPharmAthene price target raised to $6 from $4 at Aegis
Aegis raised Buy rated PharmAthene's (PIP) price target to $6 following the Delaware Court's ruling entitling it to lump sum damages from SIGA Technologies (SIGA).
News For PIP From The Last 14 Days
Check below for free stories on PIP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 16, 2014
09:25 EDTPIPOn The Fly: Pre-market Movers
Subscribe for More Information
September 11, 2014
07:25 EDTPIPAegis to hold a conference
Subscribe for More Information
September 10, 2014
09:07 EDTPIPPharmAthene awarded $28.1M contract by NIAID
Subscribe for More Information
September 9, 2014
09:08 EDTPIPPharmAthene presented non-clinical animal data on SparVax anthrax vaccine
PharmAthene announced that recent non-clinical animal data from its SparVax anthrax vaccine program were presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, or ICAAC, in Washington, DC. In a poster presentation Dr. Sherry Crowe, Director, Immunology for PharmAthene, presented an overview of non clinical animal studies of SparVax showing, among other things, that it can induce dose-dependent protective immunity in the established rabbit model for inhalational anthrax, and was statistically non-inferior to the currently licensed anthrax vaccine, BioThrax, when comparing survival and toxin neutralization assay results from the nonclinical anthrax aerosol challenge model.
September 8, 2014
10:14 EDTPIPPharmAthene, Nanotherapeutics form alliance
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use